Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

1. Efficacy and Safety of Metformin for Obesity: A Systematic Review

Efficacy and Safety of Metformin for Obesity: A Systematic Review Efficacy and Safety of Metformin for Obesity: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Show account info Close Account Logged in as: username Search: Search Save Email Send to Display (...) Format Share Permalink Copy Page navigation Review Pediatrics Actions . 2021 Mar;147(3):e20201610. doi: 10.1542/peds.2020-1610. Efficacy and Safety of Metformin for Obesity: A Systematic Review , , , , , Affiliations Expand Affiliations 1 Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada. 2 Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada. 3 Division of Endocrinology, Jewish General Hospital

2021 EvidenceUpdates

2. Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial

Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial Effect of Laparoscopic Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) Gastrectomy vs Roux-en-Y Gastric Bypass on Weight Loss and Quality of Life at 7 Years in Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland. 2 Department of Surgery, University of Turku, Turku, Finland. 3 Abdominal Center, Department of Abdominal Surgery, Helsinki University Hospital, Helsinki, Finland. 4 Department of Biostatistics

2021 EvidenceUpdates

3. Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT Full Text available with Trip Pro

Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find

2021 NIHR HTA programme

4. A balancing act: GLP-1 receptor agonists for non-diabetic obesity

Association’s recognition of obesity as a disease in 2013, signal a trend towards a more nuanced understanding of the multifactorial nature of the disease, reducing blame and stigmatization and opening doors for greater investment in therapy, including new medications like GLP-1 agonists. 7 GLP-1 agonists are a promising drug class originally developed for the treatment of type 2 diabetes, but recently shown to be effective for weight loss in non-diabetic patients with obesity or overweight BMI when given (...) intervention significantly improved weight maintenance at 56 weeks when compared with controls (who received placebo and lifestyle intervention) in overweight and obese individuals who had already lost at least 5% of initial body weight during a low-calorie diet prior to randomization. 13 Semaglutide, another GLP-1 agonist already approved for type 2 diabetes treatment, is also in ongoing trials for obesity treatment in patients without diabetes 14 and may provide a greater weight loss benefit than

2021 Clinical Correlations

5. Setmelanotide (Imcivree) - To treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency

Setmelanotide (Imcivree) - To treat obesity and the control of hunger associated with pro-opiomelanocortin deficiency Drug Approval Package: IMCIVREE U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: IMCIVREE Company: Rhythm Pharmaceuticals Inc. Application Number: 213793 Approval Date: 11/25/2020 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF

2021 FDA - Drug Approval Package

6. Treatment options for morbid obesity

. The World Health Organization defines morbid obesity as a body mass index ≥ 40 kg/m 2 or ≥ 35 kg/m 2 in patients with overweight-related comorbidity. Treatment options for morbid obesity include lifestyle interventions alone or in combination with motivational stays, surgical treatments and pharmacological treatments. We found low to moderate quality evidence indicating that, compared to lifestyle interventions alone: Lifestyle interventions with Roux-en-Y gastric bypass probably improve weight loss (...) Treatment options for morbid obesity Treatment options for morbid obesity - NIPH Search for: Søk Menu To top level Close Infectious diseases & Vaccines Mental & Physical health Environment & Lifestyle Health in Norway Quality & Knowledge Research & Access to data About NIPH Close Treatment options for morbid obesity Subscribe me! You have subscribed to alerts about: Treatment options for morbid obesity Oops, something went wrong... ... contact nettredaksjon@fhi.no. ... reload the page and try

2021 Norwegian Institute of Public Health

7. Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial

Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get (...) for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled Trial , , , , , Affiliations Expand Affiliation 1 Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, Oregon; and the Department of Anesthesia, Stanford University School of Medicine, Stanford, California. PMID: 33156201 PMCID: PMC7680383 (available on 2021-12-01 ) DOI: Item in Clipboard Alternate Dosing Protocol for Magnesium Sulfate in Obese Women With Preeclampsia: A Randomized Controlled

2021 EvidenceUpdates

8. Whole systems approach to obesity

Whole systems approach to obesity Whole systems approach to obesity - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Whole systems approach to obesity A guide and set of resources to support local authorities with implementing a whole systems approach to address obesity and promote a healthy weight. Published 25 July 2019 From: Documents Ref: PHE publications gateway number GW-534 If you use assistive (...) This guide and set of resources can be used to support the implementation of a whole systems approach to obesity. It is intended for local authorities and partners, including the NHS, local businesses and the community and voluntary sector. The guide covers: the role of local authorities the benefits of taking a whole systems approach the 6-phase process - each phase provides practical support Each phase has accompanying . Included with the guide is a separate ‘learning report’, explaining the findings

2020 Public Health England

9. Liraglutide for managing overweight and obesity

Liraglutide for managing overweight and obesity Liraglutide for managing overweight and obesity T echnology appraisal guidance Published: 9 December 2020 www.nice.org.uk/guidance/ta664 © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Your responsibility Your responsibility The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising (...) health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Liraglutide for managing overweight and obesity (TA664) © NICE 2020. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 18Contents Contents 1 Recommendations 4 2 Information about liraglutide 6 Marketing authorisation 6 Dosage in the marketing authorisation 6 Price 6 3 Committee discussion 7

2020 National Institute for Health and Clinical Excellence - Technology Appraisals

10. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study

Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set (...) options Format Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Nov 9;dc200358. doi: 10.2337/dc20-0358. Online ahead of print. Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Centers for Disease Control and Prevention, Atlanta

2020 EvidenceUpdates

11. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial Full Text available with Trip Pro

Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) Actions . 2020 Sep 28;180(11):1-9. doi: 10.1001/jamainternmed.2020.4153. Online ahead of print. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial , , , , , , , , , , , Affiliations Expand Affiliations 1 Cardiovascular Research Institute, University of California, San Francisco, San Francisco. 2 Cardiology Division, University of California, San Francisco, San Francisco. 3 Center

2020 EvidenceUpdates

12. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial Full Text available with Trip Pro

Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging (...) 2020 Apr 25. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial , , , , , , , , , , , , , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators Spanish Sleep Network : , , , , , , , , , , , , , , , , , , , , , , Affiliations 1 Respiratory Department, San Pedro de Alcántara Hospital, Cáceres, Spain; CIBER de enfermedades respiratorias (CIBERES), Madrid, Spain; Instituto Universitario de Investigación

2020 EvidenceUpdates

13. Improving the safety of shoulder arthroscopy in the beach chair position: a prospective randomized trial investigating the effect of compression stockings on cerebral desaturation events in obese patients

Improving the safety of shoulder arthroscopy in the beach chair position: a prospective randomized trial investigating the effect of compression stockings on cerebral desaturation events in obese patients Improving the safety of shoulder arthroscopy in the beach chair position: a prospective randomized trial investigating the effect of compression stockings on cerebral desaturation events in obese patients - PubMed This site needs JavaScript to work properly. Please enable it to take advantage (...) Display options Format Share Permalink Copy Page navigation J Shoulder Elbow Surg Actions . 2020 Oct;29(10):2027-2035. doi: 10.1016/j.jse.2020.05.037. Epub 2020 Jun 24. Improving the safety of shoulder arthroscopy in the beach chair position: a prospective randomized trial investigating the effect of compression stockings on cerebral desaturation events in obese patients , , , , , Affiliations Expand Affiliations 1 Loyola University Medical Center, Stritch School of Medicine, Department of Orthopaedic

2020 EvidenceUpdates

14. A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT Full Text available with Trip Pro

A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need

2020 NIHR HTA programme

15. Fit and Strong! Plus: Twelve and eighteen month follow-up results for a comparative effectiveness trial among overweight/obese older adults with osteoarthritis Full Text available with Trip Pro

Fit and Strong! Plus: Twelve and eighteen month follow-up results for a comparative effectiveness trial among overweight/obese older adults with osteoarthritis Fit and Strong! Plus: Twelve and eighteen month follow-up results for a comparative effectiveness trial among overweight/obese older adults with osteoarthritis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) . 2020 Oct 3;141:106267. doi: 10.1016/j.ypmed.2020.106267. Online ahead of print. Fit and Strong! Plus: Twelve and eighteen month follow-up results for a comparative effectiveness trial among overweight/obese older adults with osteoarthritis , , , , , , , Affiliations Expand Affiliations 1 Institute for Health Research and Policy, School of Public Health, University of Illinois at Chicago, 1747 West Roosevelt Road, Chicago, IL 60608, United States of America; University of Illinois Cancer Center, 818

2020 EvidenceUpdates

17. The Negative Impact of Obesity on the Occurrence and Prognosis of the 2019 Novel Coronavirus (COVID-19) Disease: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

The Negative Impact of Obesity on the Occurrence and Prognosis of the 2019 Novel Coronavirus (COVID-19) Disease: A Systematic Review and Meta-Analysis The Negative Impact of Obesity on the Occurrence and Prognosis of the 2019 Novel Coronavirus (COVID-19) Disease: A Systematic Review and Meta-Analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research The Negative Impact of Obesity on the Occurrence and Prognosis of the 2019 Novel Coronavirus (COVID-19) Disease: A Systematic Review and Meta-Analysis Tahereh Raeisi, Hadis Mozaffari, Nazaninzahra Sepehri, Mohammad Alizadeh, Mina Darand, Bahman Razi, Shahab alizadeh

2020 Research Square

18. Faculty Opinions recommendation of Association between Exposure to p,p'-DDT and Its Metabolite p,p'-DDE with Obesity: Integrated Systematic Review and Meta-Analysis. Full Text available with Trip Pro

Faculty Opinions recommendation of Association between Exposure to p,p'-DDT and Its Metabolite p,p'-DDE with Obesity: Integrated Systematic Review and Meta-Analysis. Association between Exposure to p,p'-DDT and Its... | Faculty Opinions On April 12th, 2020, F1000Prime became Faculty Opinions. See our to learn more. Welcome Guest 1 Recommendations info_outline Systematic Review / Meta-analysis New Finding close Classified As New Finding 1 Article Type Systematic Review / Meta-analysis More (...) more_vert close Download article Export article Sciwheel Download citation BibTeX RIS Share Email Association between Exposure to p,p'-DDT and Its Metabolite p,p'-DDE with Obesity: Integrated Systematic Review and Meta-Analysis. ARTICLE PUBLISHED: 2017 09 18 CITE AS: Environ Health Perspect. 2017 09 18 ; 125 ( 9 ): 096002 Recommendations Abstract Comments You have reached your article limit. Register for 30-day free trial Registration is free and only takes a moment, or subscribe for unlimited access

2020 Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

19. Management of Adult Overweight and Obesity

Management of Adult Overweight and Obesity VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF ADULT OVERWEIGHT AND OBESITY Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard of care and should (...) and/or therapeutic interventions within these guidelines does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor. Version 3.0 – 2020VA/DoD Clinical Practice Guideline for the Management of Adult Overweight and Obesity July 2020 Page 2 of 147 Prepared by: The Management of Adult Overweight and Obesity Work Group With support from: The Office of Quality and Patient

2020 VA/DoD Clinical Practice Guidelines

20. Effect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean Delivery: A Randomized Clinical Trial. (Abstract)

Effect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean Delivery: A Randomized Clinical Trial. Obesity increases the risk of both cesarean delivery and surgical-site infection. Despite widespread use, it is unclear whether prophylactic negative pressure wound therapy reduces surgical-site infection after cesarean delivery in obese women.To evaluate whether prophylactic negative pressure wound therapy, initiated (...) immediately after cesarean delivery, lowers the risk of surgical-site infections compared with standard wound dressing in obese women.Multicenter randomized trial conducted from February 8, 2017, through November 13, 2019, at 4 academic and 2 community hospitals across the United States. Obese women undergoing planned or unplanned cesarean delivery were eligible. The study was terminated after 1624 of 2850 participants were recruited when a planned interim analysis showed increased adverse events

2020 JAMA